Showing results (11-20 of 65) with videos related to
Sort By:
Pageof 7
British Journal of Cancer|December 17, 2009
Biomarkers of angiogenesis and their role in the development of VEGF inhibitorsN Murukesh, C Dive, G C JaysonBritish Journal of Cancer|November 13, 2008
Antiangiogenic drugs in ovarian cancerG C Kumaran, G C Jayson, A R ClampEuropean Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 30, 2006
The interval from surgery to chemotherapy in the treatment of advanced epithelial ovarian carcinomaD D Rosa, A Clamp, S Mullamitha, et al.Journal of Cancer Research and Clinical Oncology|January 12, 2001
Metallothionein expression in epithelial ovarian cancer: effect of chemotherapy and prognostic significanceE Wrigley, H W Verspaget, G C Jayson, et al.British Journal of Cancer|November 17, 2001
Heparan sulfate proteoglycans and cancerF H Blackhall, C L Merry, E J Davies, et al.British Journal of Cancer|August 14, 1998
A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancerG C Jayson, M Middleton, S M Lee, et al.British Journal of Cancer|January 11, 2007
DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agentsJ P B O'Connor, A Jackson, G J M Parker, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Phase I evaluation of CDP791, a PEGylated di-Fab' conjugate that binds vascular endothelial growth factor receptor 2N C Ton, G J M Parker, A Jackson, et al.Cancer Research|November 1, 1994
Basic fibroblast growth factor increases the multiplication and migration of a serum-free derivative of CACO-2 but does not affect differentiationG C Jayson, G S Evans, P W Pemberton, et al.Cancer|December 15, 1994
Carcinomatous meningitis in patients with breast cancer. An aggressive disease variantG C Jayson, A Howell, M Harris, et al.Pageof 7